Israel
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
11,374.13%
|
Dec. 31, 2023 | USD 0.02 | -4.22% |
|
Israel |
|
2 |
7.06%
|
Dec. 31, 2023 | USD 6.96 | 3.55% |
|
Israel |
|
3 |
6.52%
|
Dec. 31, 2023 | USD 2.37 | 3.33% |
|
Israel |
|
4 |
-38.83%
|
Dec. 31, 2023 | USD 2.38 | 4.02% |
|
Israel |
|
5 |
-67.63%
|
Dec. 31, 2023 | USD 2.86 | -0.54% |
|
Israel |
|
6 |
-206.64%
|
Dec. 31, 2023 | USD 0.11 | 3.21% |
|
Israel |
|
7 |
-1,035.29%
|
Dec. 31, 2023 | USD 0.01 | -3.84% |
|
Israel |
The Vaccines company in Israel with the highest Operating Income Margin is Purple Biotech Ltd. (Tel Aviv Stock Exchange: PPBT.TA) at 11,374.13%.
The Vaccines company in Israel with the lowest Operating Income Margin is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at -1,035.29%.
The top 10 Vaccines companies in Israel by Operating Income Margin are Purple Biotech Ltd., Kamada Ltd., Bait Vegag Real Estate Development Ltd, Compugen Ltd., Epitomee Medical Ltd, Tikun Olam-Cannbit Pharmaceuticals Ltd and BioLineRx Ltd..
The bottom 10 Vaccines companies in Israel by Operating Income Margin are BioLineRx Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Epitomee Medical Ltd, Compugen Ltd., Bait Vegag Real Estate Development Ltd, Kamada Ltd. and Purple Biotech Ltd..